FDA Says Retailers Didn’t Remove Recalled Formula Fast Enough

The FDA posted its warning letters on December 12, naming Walmart, Target, Kroger, and Albertsons for failing to quickly ...

FDA sends warning letters to Walmart, Target for selling recalled baby formula

Four major retailers kept ByHeart infant formula on store shelves even after being notified of the recall, the FDA said. The ...

FDA commissioner on growing public mistrust of government health advice

FDA Commissioner Martin Makary discusses vaccine policy, COVID-era decisions and the erosion of trust in government health ...

FDA sends warning letters to major retailers for selling recalled formula linked to infant botulism outbreak

The US Food and Drug Administration sent warning letters to Target, Walmart, Kroger and Albertsons after some of the stores failed to remove recalled baby formula linked to a large infant botulism ...

Big retailers didn’t pull ByHeart baby formula fast enough after botulism recall, FDA says

The U.S. Food and Drug Administration sent warning letters to four top retail stores for failing to promptly pull ...

FDA says it may relax warning label rule for dietary supplements

Supplements aren’t reviewed for safety and effectiveness, but disclaimers about health benefits are required on products.

FDA OKs libido-boosting pill for older women who have gone through menopause

U.S. health officials have expanded approval of a drug that boosts libido in women who report stress due to a low sex drive.

FDA has no plans to put most serious warning on COVID vaccines, Bloomberg News reports

The U.S. Food and Drug Administration has no plans to put a "black box" warning on COVID-19 vaccines, Bloomberg News reported ...

FDA mulls strongest safety warning for COVID-19 vaccines

The U.S. Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines, ...

FDA approves first at-home device for depression. What is it?

The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to ...

Sanofi flags second delay to FDA decision on multiple sclerosis drug, shares fall

Shares of French pharmaceutical group Sanofi fell 4% on Monday after it flagged another delay to a U.S. regulatory decision ...

FDA OKs libido-boosting pill for women who have gone through menopause

US health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill ...